Tag: Xcath

XCath Secures $30 Million Series C to Improve Global Outcomes in Neurovascular Care

Financial by 0 comments

HOUSTON–(BUSINESS WIRE)–XCath, a medical device company pioneering neuro-endovascular surgical robotics, announced today that it has secured $30 million in Series C funding, bringing the total raised since the company’s inception to $92 million. The round was co-led by Crescent Enterprises and by Dr. Fred Moll, Chairman of the XCath Board of Directors. These latest funds will support XCath’s ongoing efforts to bring the world’s first commercially-practical endovascular robot to the market and

Continue Reading →

XCath Endovascular Robotic System Successfully Performs its First-In-Human Brain Aneurysm Procedures

Neuro by 0 comments

HOUSTON–(BUSINESS WIRE)–XCath, a medical device company dedicated to pioneering neuro-endovascular surgical robotics, announced today the successful first-in-human use of its EVR robotic system to treat three patients with complex brain aneurysms. The landmark procedures were performed at The Panama Clinic in Panama City, Panama, led by Vitor Mendes Pereira, M.D., […]

Continue Reading →

XCath CEO Eduardo Fonseca Highlights Potential for Telesurgery at Inaugural SRS Telesurgery Consensus Conference

Uncategorized by Comments are Disabled

HOUSTON–(BUSINESS WIRE)–XCath, an early-stage medical device company dedicated to expanding endovascular treatment modalities through its robotic systems and guidewires, took part in a panel last week at the first-ever Telesurgery Consensus Conference hosted by the Society of Robotic Surgery (SRS). The event, which took place in Orlando, Florida from February 3-4, provided a forum for international leaders in the surgical and robotic spaces to examine priorities and challenges in the ever-cha

Continue Reading →